Yongxian Hu

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 17

Top Topics

Intellectual Disability

Epstein Barr Virus

Rheumatoid Arthritis Patients

Top Venues

Cell transplantation

Bone marrow transplantation

Infection and drug resistance

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Chunlan Fu, Yuanyuan Zhu, Weijia Huang, Yi Luo, Yongxian Hu, He Huang, Jie Sun
Using Tocilizumab in Hematologic Malignant Patients with Severe COVID-19 Infection - Case Series Report. Infection and drug resistance 17 (2024)
Tingting Yang, Rongrong Chen, Mingming Zhang, Ruirui Jing, Jia Geng, Guoqing Wei, Yi Luo, Pingnan Xiao, Ruimin Hong, Jingjing Feng, Shan Fu, Houli Zhao, Jiazhen Cui, Simao Huang, He Huang, Yongxian Hu
Relapsed/Refractory Peripheral T-Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis With UNC13D and CD27 Germline Mutations. Cell transplantation 33 (2024)
Tingting Yang, Rongrong Chen, Mingming Zhang, Ruirui Jing, Jia Geng, Guoqing Wei, Yi Luo, Pingnan Xiao, Ruimin Hong, Jingjing Feng, Shan Fu, Houli Zhao, Jiazhen Cui, Simao Huang, He Huang, Yongxian Hu
Relapsed/Refractory Peripheral T-Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis With UNC13D and CD27 Germline Mutations. Cell transplantation 33 (2024)
Chunlan Fu, Yuanyuan Zhu, Weijia Huang, Yi Luo, Yongxian Hu, He Huang, Jie Sun
Using Tocilizumab in Hematologic Malignant Patients with Severe COVID-19 Infection - Case Series Report. Infection and drug resistance 17 (2024)
Tingting Yang, Rongrong Chen, Mingming Zhang, Ruirui Jing, Jia Geng, Guoqing Wei, Yi Luo, Pingnan Xiao, Ruimin Hong, Jingjing Feng, Shan Fu, Houli Zhao, Jiazhen Cui, Simao Huang, He Huang, Yongxian Hu
Relapsed/Refractory Peripheral T-Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis With UNC13D and CD27 Germline Mutations. Cell transplantation 33 (2024)
Shan Fu, Qiqi Zhang, Ruirui Jing, Cheng Zu, Fang Ni, Yuqi Lv, Jiazhen Cui, Haiqiong Zheng, Yanlei Zhang, Mingming Zhang, Guoqing Wei, Zenan Cen, Alex H Chang, Yongxian Hu, He Huang
HBV reactivation in patients with chronic or resolved HBV infection following BCMA-targeted CAR-T cell therapy. Bone marrow transplantation (2023)
Yingying Li, Yixue Li, Mingming Zhang, Houli Zhao, Miaoyong Zhu, He Huang, Yongxian Hu
Donor-derived stem cell infusion for sustained pancytopenia after CD19 CAR-T therapy for relapsed patients post allogeneic stem cell transplantation. European journal of haematology (2023)
Linghui Zhou, Weijun Fu, Shenghao Wu, Kailin Xu, Lugui Qiu, Yang Xu, Xiao-Jing Yan, Qing Zhang, Mingming Zhang, Linqin Wang, Ruimin Hong, Alex H Chang, Jian Yu, Shan Fu, Delin Kong, Lu Li, Ying Wang, Zhenyu Li, Huawei Jiang, Jing Huang, Zhi Liu, Na Su, Guoqing Wei, Yongxian Hu, He Huang
Derivation and validation of a novel score for early prediction of severe CRS after CAR-T therapy in haematological malignancy patients: A multi-centre study. British journal of haematology (2023)
Xueer Xu, Cheng Zu, Mingming Zhang, Pingnan Xiao, Ruimin Hong, Jingjing Feng, Huijun Xu, Jiazhen Cui, Jian Yu, Jimin Shi, Guoqing Wei, Alex H Chang, He Huang, Yongxian Hu
HLA Fully-Mismatched Sibling-Derived CD7 CAR-T Therapy Bridging to Haploidentical Hematopoietic Stem Cell Transplantation for Hepatosplenic γδ T-cell Lymphoma. Cell transplantation 32 (2023)
Cheng Zu, Yufeng Xu, Yiyun Wang, Mingming Zhang, Houli Zhao, Xiaoyun Fang, He Huang, Yongxian Hu
Cytomegalovirus Retinitis and Retinal Detachment following Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory Multiple Myeloma. Current oncology (Toronto, Ont.) 29 (2) (2022)
Tianning Gu, Kejia Hu, Xiaohui Si, Yongxian Hu, He Huang
Mechanisms of immune effector cell-associated neurotoxicity syndrome after CAR-T treatment. WIREs mechanisms of disease 14 (6) (2022)
Mi Shao, Xinyi Teng, Xin Guo, Hao Zhang, Yue Huang, Jiazhen Cui, Xiaohui Si, Lijuan Ding, Xiujian Wang, Xia Li, Jimin Shi, Mingming Zhang, Delin Kong, Tianning Gu, Yongxian Hu, Pengxu Qian, He Huang
Inhibition of Calcium Signaling Prevents Exhaustion and Enhances Anti-Leukemia Efficacy of CAR-T Cells via SOCE-Calcineurin-NFAT and Glycolysis Pathways. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 9 (9) (2022)
Huafeng Wang, Chang Yang, Ting Shi, Yi Zhang, Jiejing Qian, Yungui Wang, Yongxian Hu, Liping Mao, Xiujin Ye, Fang Liu, Zhenfang Xi, Lihong Shou, Caiyun Fu, Hua Naranmandura, Jie Jin, Hong Hu Zhu
Venetoclax-ponatinib for T315I/compound-mutated Ph+ acute lymphoblastic leukemia. Blood cancer journal 12 (1) (2022)
Yue Huang, Houli Zhao, Mi Shao, Linghui Zhou, Xiaoqing Li, Guoqing Wei, Wenjun Wu, Jiazhen Cui, Alex H Chang, Tao Sun, Yongxian Hu, He Huang
Predictive value of next-generation sequencing-based minimal residual disease after CAR-T cell therapy. Bone marrow transplantation 57 (8) (2022)
Jingjing Feng, Mi Shao, Yongxian Hu, He Huang
Profile of capillary-leak syndrome in patients received chimeric antigen receptor T cell therapy. Bone marrow transplantation 57 (4) (2022)
Feng Zhu, Guoqing Wei, Yandan Liu, Houli Zhou, Wenjun Wu, Luxin Yang, He Huang, Yongxian Hu
Incidence and Risk Factors Associated with Infection after Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory B-cell Malignancies. Cell transplantation 30 (2021)
Yiyun Wang, Yingying Yang, Ruimin Hong, Houli Zhao, Guoqing Wei, Wenjun Wu, Huijun Xu, Jiazhen Cui, Yanlei Zhang, Alex H Chang, Yongxian Hu, He Huang
A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia. Blood cancer journal 10 (10) (2020)